Induction of sensitivity to activation-induced death in primary CD4(+) cells: A role for interleukin-2 in the negative regulation of responses by mature CD4(+) T cells

被引:47
作者
Wang, RD [1 ]
Rogers, AM [1 ]
Rush, BJ [1 ]
Russell, JH [1 ]
机构
[1] WASHINGTON UNIV,SCH MED,DEPT MOL BIOL & PHARMACOL,ST LOUIS,MO 63110
关键词
interleukin-2; activation-induced death; CD95; lymphocyte regulation;
D O I
10.1002/eji.1830260944
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We examine the requirements for converting naive, mature CD4(+) cells from an activation-induced death (AID)-resistant to a -sensitive phenotype. Priming for sensitivity to AID can be divided into two steps. The first is a mitogen/CD3-dependent, cyclosporin-sensitive signal and the second a cytokine-dependent, cyclosporin-insensitive one. Under these conditions, interleukin (IL)-2, but not IL-4, IL-7 or IL-15, the receptors of which share a common receptor gamma chain, is capable of providing the cytokine signal for inducing sensitivity to AID. Increased expression of the low-affinity IL-2R alpha chain (CD25) is associated with acquisition of AID sensitivity and antibodies to CD25 block acquisition of AID sensitivity in the presence of IL-2. As with T cell hybridomas, AID is dependent on both CD95 and CD95 ligand (CD95L) expression, but unlike hybridomas, the sensitive and resistant phenotypes of primary CD4(+) cells cannot be distinguished by levels of CD95 expression, functional CD95L nor the fraction of cells in cycle. The results suggest that the unique function of IL-2 is to regulate proteins, either not important or constitutively regulated in T cell hybridomas, that are essential for cell-autonomous suicide of activated CD4(+) cells. These experiments provide a mechanism for the recent observations of chronic lymphoproliferation and autoimmune disease in mice with null mutations in IL-2 or CD25.
引用
收藏
页码:2263 / 2270
页数:8
相关论文
共 56 条
  • [21] NORMAL CLONAL EXPANSION BUT IMPAIRED FAS-MEDIATED CELL-DEATH AND ANERGY INDUCTION IN INTERLEUKIN-2-DEFICIENT MICE
    KNEITZ, B
    HERRMANN, T
    YONEHARA, S
    SCHIMPL, A
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (09) : 2572 - 2577
  • [22] FUNCTIONAL PARTICIPATION OF THE IL-2 RECEPTOR-GAMMA CHAIN IN IL-7 RECEPTOR COMPLEXES
    KONDO, M
    TAKESHITA, T
    HIGUCHI, M
    NAKAMURA, M
    SUDO, T
    NISHIKAWA, SI
    SUGAMURA, K
    [J]. SCIENCE, 1994, 263 (5152) : 1453 - 1454
  • [23] SHARING OF THE INTERLEUKIN-2 (IL-2) RECEPTOR GAMMA-CHAIN BETWEEN RECEPTORS FOR IL-2 AND IL-4
    KONDO, M
    TAKESHITA, T
    ISHII, N
    NAKAMURA, M
    WATANABE, S
    ARAI, K
    SUGAMURA, K
    [J]. SCIENCE, 1993, 262 (5141) : 1874 - 1877
  • [24] INTERLEUKIN-2 PROGRAMS MOUSE ALPHA-BETA-LYMPHOCYTES-T FOR APOPTOSIS
    LENARDO, MJ
    [J]. NATURE, 1991, 353 (6347) : 858 - 861
  • [25] GENETIC-CHARACTERIZATION OF A POLYMORPHIC MURINE CELL-SURFACE GLYCOPROTEIN
    LESLEY, J
    TROWBRIDGE, IS
    [J]. IMMUNOGENETICS, 1982, 15 (03) : 313 - 320
  • [26] LIU Y, 1990, Journal of Experimental Medicine, V172, P1735, DOI 10.1084/jem.172.6.1735
  • [27] IDENTIFICATION AND INITIAL CHARACTERIZATION OF A RAT MONOCLONAL-ANTIBODY REACTIVE WITH THE MURINE INTERLEUKIN-2 RECEPTOR LIGAND COMPLEX
    MALEK, TR
    ROBB, RJ
    SHEVACH, EM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1983, 80 (18): : 5694 - 5698
  • [28] THE IL-2 RECEPTOR COMPLEX - ITS STRUCTURE, FUNCTION, AND TARGET GENES
    MINAMI, Y
    KONO, T
    MIYAZAKI, T
    TANIGUCHI, T
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 1993, 11 : 245 - 268
  • [29] MOSSMAN TR, 1986, J IMMUNOL, V136, P2348
  • [30] DIFFERENCES IN THE INTERLEUKIN-2 (IL-2) RECEPTOR SYSTEM IN HUMAN AND MOUSE - ALPHA-CHAIN IS REQUIRED FOR FORMATION OF THE FUNCTIONAL-MOUSE IL-2 RECEPTOR
    NEMOTO, T
    TAKESHITA, T
    ISHII, N
    KONDO, M
    HIGUCHI, M
    SATOMI, S
    NAKAMURA, M
    MORI, S
    SUGAMURA, K
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (11) : 3001 - 3005